Wall Street brokerages forecast that Addus Homecare Co. (NASDAQ:ADUS) will announce $140.27 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for Addus Homecare’s earnings, with the lowest sales estimate coming in at $137.50 million and the highest estimate coming in at $143.66 million. Addus Homecare posted sales of $111.96 million during the same quarter last year, which indicates a positive year-over-year growth rate of 25.3%. The company is scheduled to issue its next quarterly earnings report on Monday, March 4th.

On average, analysts expect that Addus Homecare will report full year sales of $518.59 million for the current year, with estimates ranging from $515.80 million to $521.97 million. For the next year, analysts forecast that the business will post sales of $610.64 million, with estimates ranging from $572.95 million to $652.00 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Addus Homecare.

Addus Homecare (NASDAQ:ADUS) last posted its earnings results on Tuesday, November 6th. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.08. The company had revenue of $137.63 million for the quarter, compared to the consensus estimate of $139.43 million. Addus Homecare had a return on equity of 9.55% and a net margin of 3.25%.

A number of research firms recently commented on ADUS. Zacks Investment Research downgraded Addus Homecare from a “hold” rating to a “strong sell” rating in a research report on Monday, August 13th. BidaskClub upgraded Addus Homecare from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 30th. Robert W. Baird reiterated a “hold” rating and issued a $65.00 target price on shares of Addus Homecare in a research report on Wednesday, August 8th. Oppenheimer boosted their target price on Addus Homecare from $50.00 to $72.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 8th. Finally, ValuEngine upgraded Addus Homecare from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 4th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company. Addus Homecare presently has a consensus rating of “Buy” and a consensus target price of $73.50.

Shares of NASDAQ:ADUS traded down $0.21 during mid-day trading on Monday, reaching $76.13. The stock had a trading volume of 211,512 shares, compared to its average volume of 114,649. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $999.93 million, a P/E ratio of 52.50, a P/E/G ratio of 3.02 and a beta of -0.27. Addus Homecare has a 1 year low of $31.20 and a 1 year high of $77.82.

In other Addus Homecare news, EVP Laurie Manning sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 19th. The stock was sold at an average price of $71.91, for a total transaction of $71,910.00. Following the sale, the executive vice president now directly owns 11,537 shares of the company’s stock, valued at $829,625.67. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Brian Poff sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $73.76, for a total value of $368,800.00. Following the sale, the chief financial officer now directly owns 17,770 shares in the company, valued at $1,310,715.20. The disclosure for this sale can be found here. Insiders have sold 923,400 shares of company stock worth $66,935,850 over the last three months. 34.80% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Eos Management L.P. grew its stake in shares of Addus Homecare by 4,991.1% during the third quarter. Eos Management L.P. now owns 190,221,406 shares of the company’s stock valued at $2,712,000 after buying an additional 186,485,035 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Addus Homecare by 1.7% during the second quarter. Dimensional Fund Advisors LP now owns 913,787 shares of the company’s stock valued at $52,317,000 after buying an additional 15,487 shares during the last quarter. BlackRock Inc. grew its stake in shares of Addus Homecare by 24.9% during the third quarter. BlackRock Inc. now owns 731,017 shares of the company’s stock valued at $51,281,000 after buying an additional 145,736 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Addus Homecare by 48.5% during the third quarter. Vanguard Group Inc. now owns 544,748 shares of the company’s stock valued at $38,214,000 after buying an additional 177,827 shares during the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of Addus Homecare by 47.8% during the third quarter. Renaissance Technologies LLC now owns 271,547 shares of the company’s stock valued at $19,049,000 after buying an additional 87,847 shares during the last quarter. 92.89% of the stock is currently owned by institutional investors.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Featured Article: Investing strategies using the yield curve

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.